A detailed history of Harvest Fund Management Co., LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 20,523 shares of LLY stock, worth $15.5 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
20,523
Previous 17,528 17.09%
Holding current value
$15.5 Million
Previous $15.9 Million 14.58%
% of portfolio
1.09%
Previous 1.16%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $2.31 Million - $2.88 Million
2,995 Added 17.09%
20,523 $18.2 Million
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $3.61 Million - $4.53 Million
4,978 Added 39.67%
17,528 $15.9 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1.98 Million - $2.65 Million
3,346 Added 36.35%
12,550 $9.76 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $186,442 - $219,791
355 Added 4.01%
9,204 $5.37 Million
Q3 2023

Nov 06, 2023

BUY
$434.7 - $599.3 $460,782 - $635,258
1,060 Added 13.61%
8,849 $4.75 Million
Q2 2023

Jul 07, 2023

BUY
$350.74 - $468.98 $372,485 - $498,056
1,062 Added 15.79%
7,789 $3.65 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $446,375 - $524,246
-1,437 Reduced 17.6%
6,727 $2.31 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $255,953 - $298,237
796 Added 10.8%
8,164 $2.99 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $173,440 - $197,653
585 Added 8.62%
7,368 $2.38 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $300,192 - $352,469
1,077 Added 18.87%
6,783 $2.2 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $507,165 - $630,277
-2,161 Reduced 27.47%
5,706 $1.63 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $187,300 - $232,440
833 Added 11.84%
7,867 $2.18 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $348,576 - $428,972
1,573 Added 28.8%
7,034 $1.62 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $78,539 - $101,589
435 Added 8.65%
5,461 $1.26 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $322,231 - $417,143
1,961 Added 63.98%
5,026 $938,000
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $307,233 - $406,543
-2,355 Reduced 43.45%
3,065 $517,000
Q3 2020

Nov 04, 2020

SELL
$146.22 - $169.13 $62,143 - $71,880
-425 Reduced 7.27%
5,420 $794,000
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $13,641 - $16,418
100 Added 1.74%
5,845 $954,000
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $331,673 - $410,517
2,786 Added 94.15%
5,745 $795,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $5,239 - $6,489
-49 Reduced 1.63%
2,959 $548,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $70,588 - $76,781
661 Added 28.16%
3,008 $336,000
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $306,334 - $357,569
-2,765 Reduced 54.09%
2,347 $260,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $92,387 - $108,746
-830 Reduced 13.97%
5,112 $663,000
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $89,803 - $100,606
-848 Reduced 12.49%
5,942 $688,000
Q3 2018

Oct 31, 2018

BUY
$85.86 - $107.31 $582,989 - $728,634
6,790 New
6,790 $729,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.